AUS
NZ
UK
CA
USA
IND
Healthcare
BPH Global Expands Seaweed R&D with Gaia Mariculture
November 26, 2024 03:17 PM AEDT| By Team Kalkine MediaHighlights,BPH Global reappoints Gaia Mariculture for advanced seaweed R&D in Singapore.,Scope includes AI, blockchain integration, and sustainable farming innovations.,Research to explore seaweed's role in critical mineral extraction and carbon capt...
Key Developments and Alliances at Immutep Noted
November 26, 2024 03:11 PM AEDT| By Team Kalkine MediaHighlights:,Immutep Limited achieves significant progress in autoimmune disease treatments.,Landmark partnership with Merck enhances development capabilities.,Promising clinical trial results pave the way for future advancements.,In a year marked by...
EZZ Life Sciences has referred to the Chinese consumer market as a thing of beauty
November 25, 2024 04:57 PM AEDT| By Team Kalkine MediaHighlights:,EZZ Life Sciences (ASX:EZZ) reports strong sales growth during the 11.11 Global Shopping Festival in China, marking a significant improvement over last year.,Truscreen Group (ASX: TRU) signs a deal with Ho Chi Minh City health authorities...
4DMedical is set to supply lung imaging technology to a US radiology company after winning the contract
November 25, 2024 04:44 PM AEDT| By Team Kalkine MediaHighlights:,4DMedical (ASX:4DX) has secured a contract with Imaging Partners of Orange County (IPOC) for lung ventilation and density analysis using CT scans.,The contract, extending through March 2026, marks 4DMedical’s first deal with an independen...
Revolutionizing Cervical Cancer Screening: TruScreen Group’s Initiative in Vietnam
November 25, 2024 04:17 PM AEDT| By Team Kalkine MediaHighlights,TruScreen,Group to launch a five-year cervical screening program in Vietnam,.,Partnership,established,with Ho Chi Minh City Public Health Association and Gorton Health Services,.,Program aims to screen around,260,000 women,using innovative...
Neurotech Advances NTI164 Research with New Pharmacokinetic Study
November 25, 2024 03:04 PM AEDT| By Team Kalkine MediaHighlights,Neurotech initiates a new study following FDA decision,.,Focus is on NTI164's pharmacokinetics in healthy adults,.,Study results expected by the first quarter of 2025,.,Neurotech (ASX:NTI) has moved forward with a new baseline data study f...
4DMedical Signs Key Commercial Contract with Imaging Partners of Orange County, Shares Rise 3.3%
November 25, 2024 01:38 PM AEDT| By Team Kalkine MediaHighlights,Partnership,: 4DMedical has secured a,commercial contract,with,Imaging Partners of Orange County (IPOC),for CT LVAS™ and Lung Density Analysis™ (LDAf) scans.,Significant Milestone,: This is the company’s first contract with an independent...
Anteris Technologies Sets Eyes on NASDAQ with Early-Stage IPO Filing
November 25, 2024 01:28 PM AEDT| By Team Kalkine MediaHighlights,Anteris,Technologies files preliminary paperwork for potential NASDAQ listing,.,Focus,remains,on flagship next-gen heart valve technology and R&D activities,.,Australian companies are increasingly exploring US markets for liquidity options...
Pro Medicus Shares Hit Record High Amid Strong Growth Outlook
November 25, 2024 11:52 AM AEDT| By Team Kalkine MediaHighlights,Record Performance,: Pro Medicus shares surged to a record high of AU$226.79 on Monday, marking a 160% increase year-over-year.,Impressive Financials,: FY24 saw revenue grow by 29.3% and net profit after tax by 36.5%.,Growth Opportunities,...
CSL Shares See Uptick Amid Downplayed Policy Concerns
November 22, 2024 07:03 PM AEDT| By Team Kalkine MediaHighlights,Shares of gain traction following reassessment of US policy risks.,CSL’s vaccine business and broader pharmaceuticals face limited potential impact.,Plasma collection and essential products bolster CSL’s resilience in uncertain times.,CSL...
PYC Therapeutics Showcases Progress in Eye Disease Treatment at Global Conference
November 22, 2024 06:49 PM AEDT| By Team Kalkine MediaHighlights,PYC Therapeutics presents trial data for VP-001 at a major conference.,Phase 1/2 studies focus on treating Retinitis Pigmentosa Type 11.,Preparations for FDA discussions regarding a registrational trial are underway.,PYC Therapeutics (ASX:...
Tryptamine Therapeutics Completes First Dosing in Obesity Study for Psilocin-Based Treatment
November 22, 2024 04:50 PM AEDT| By Team Kalkine MediaHighlights,Clinical Progress:,First subject dosed in a Phase 1b study evaluating TRP-8803 in obese participants.,Study Goals:,Aims to assess pharmacokinetic differences compared to non-obese patients.,Advancing to Phase 2:,Data will optimize dosing f...
Alcidion Secures Major Deal with Peninsula Health for Miya Precision Platform
November 22, 2024 03:51 PM AEDT| By Team Kalkine MediaHighlights,Alcidion,signs a five-year contract with Peninsula Health.,Miya Precision platform to enhance patient data management and hospital operations.,Advanced technology aims to reduce administrative workload on hospital staff.,Alcidion (ASX:ALC)...
Healthscope Cancels Bupa Deal, Increasing Costs for Millions
November 22, 2024 12:22 PM AEDT| By Team Kalkine MediaHighlights:,Termination of Healthscope-Bupa Agreement:,Healthscope (,ASX:HSO,) has,terminated,its agreement with Bupa and other not-for-profit insurers, affecting 6.5 million Australians who may face higher medical costs starting February 1.,Financia...
Millions of Australians Face Loss of Coverage at 38 Private Hospitals
November 22, 2024 12:14 PM AEDT| By Team Kalkine MediaHighlights:,Coverage Termination,:,Over 6 million Australians are set to lose coverage at 38 private hospitals due to Healthscope's withdrawal from agreements with major health insurers, including Bupa and AHSA.,Financial Dispute,:,The move highlight...
Tryptamine Therapeutics (ASX:TYP) Advances Obesity-Focused Psilocin Study
November 22, 2024 11:36 AM AEDT| By Team Kalkine MediaHighlights,Tryptamine Therapeutics administers TRP-8803 to the first obese participant in a Phase 1b study.,Study explores pharmacokinetics differences between obese and non-obese participants.,Interim results expected this year to inform future tria...
Race Oncology (ASX:RAC) Advances FTO Drug Discovery
November 22, 2024 11:34 AM AEDT| By Team Kalkine MediaHighlights,Discovery of 39 molecular candidates targeting the m6A RNA demethylase protein.,Findings,validated,using advanced NMR spectroscopy and resonance techniques.,Innovative drug discovery approach,leveraging,RNA epigenetics for disease treatmen...
Algorae Pharma Advances Drug Development with AlgoraeOS
November 21, 2024 04:39 PM AEDT| By Team Kalkine MediaHighlights,Algorae,Pharmaceuticals,identifies,24 new drug targets using AI,.,Preclinical studies to assess targets for oncology treatments,.,Expansion of AI-powered drug platform to Version 2.0 announced,.,Algorae Pharmaceuticals (ASX:1AI) has unveil...
Knosys Secures Two-Year Contract Extension with Healthdirect
November 21, 2024 04:21 PM AEDT| By Team Kalkine MediaHighlights,Knosys extends SaaS contract with,Healthdirect,until 2027,.,KnowledgeIQ,continues as a core tool in healthcare and beyond,.,Shares of Knosys show growth over the past year,.,Knosys (ASX:KNO), a leading provider of knowledge management solu...
Race Oncology Identifies 39 FTO Inhibitors for Cancer Therapy
November 21, 2024 04:18 PM AEDT| By Team Kalkine MediaHighlights,Race Oncology discovers 39 molecules targeting cancer-linked proteins,.,Focus on FTO inhibition, key in cancer RNA regulation,.,Collaboration with Monash University boosts oncology research,.,Race Oncology (ASX:RAC) has successfully comple...
Advertise your brand on Kalkine Media